GP Vivas · sexual-health-and-gender-diversity
STI screening and management — structured viva
Structured oral on STI care: defending site-specific testing, the doxycycline-first shift, gonorrhoea resistance strategy, serology traps, partner notification economics, and PrEP counselling.
On this page
Study tools
Target exams
RACGP CCEFRACGP oralsMRCGP SCA
Prompt
The examiner opens: 'You order three swabs and two bloods for a man with no symptoms — justify yourself.' The viva branches through extragenital yield, chlamydia therapy, resistance, serology interpretation and partner management.
Stem
You are the GP. A colleague calls your screening panel 'over-investigation'. [1]
References5ShowHide
- [1]Aaron KJ, Gaydos CA, Hook EW 3rd, et al. Chlamydia and Gonorrhea Infections in Genital and Extragenital Samples Among Men and Women Sex Transm Dis, 2025.PMID 40772619
- [2]Lau A, Kong FYS, Fairley CK, et al. Azithromycin or Doxycycline for Asymptomatic Rectal Chlamydia trachomatis N Engl J Med, 2021.PMID 34161706
- [3]Kong FY, Tabrizi SN, Fairley CK, et al. The efficacy of azithromycin and doxycycline for the treatment of rectal chlamydia infection: a systematic review and meta-analysis J Antimicrob Chemother, 2015.PMID 25637520
- [4]Golden MR, Kerani RP, Stenger M, et al. Uptake and population-level impact of expedited partner therapy (EPT) on Chlamydia trachomatis and Neisseria gonorrhoeae: the Washington State community-level randomized trial of EPT PLoS Med, 2015.PMID 25590331
- [5]Okwundu CI, Uthman OA, Okoromah CA Antiretroviral pre-exposure prophylaxis (PrEP) for preventing HIV in high-risk individuals Cochrane Database Syst Rev, 2012.PMID 22786505